title: Pandemic influenza vaccination coverage in children with type 1 diabetes: analysis from seven Italian centers.
abstract: The pandemic influenza vaccination coverage in children with type 1 diabetes has been analysed. 1461 charts have been reviewed (788 M and 673 F, ages 13.0±4.1 yrs, disease duration 6.0±4.8 yrs, HbA1c 7.9±1.2%). Among them, 428 patients (29.3%) underwent A/H1N1 vaccination. A special effort is required to implement an increased immunization rate.
authors: Department of Pediatrics, University of Turin, Turin, Italy.
authors: Ivana
authors: I
authors: Rabbone
authors: Andrea E
authors: AE
authors: Scaramuzza
authors: Dario
authors: D
authors: Iafusco
authors: Riccardo
authors: R
authors: Bonfanti
authors: Fortunato
authors: F
authors: Lombardo
authors: Valentino
authors: V
authors: Cherubini
authors: Sonia
authors: S
authors: Toni
authors: Franco
authors: F
authors: Cerutti
authors: Gian Vincenzo
authors: GV
authors: Zuccotti
mesh_terms: D000293:Adolescent; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology / Q000276:immunology; D005260:Female; D006776:Hospitals, Pediatric; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D007558:Italy; D008297:Male; D058873:Pandemics; D014611:Vaccination / Q000706:statistics & numerical data*
chemical_list: D007252:Influenza Vaccines